Biomarker And Immuno-oncology World Congress
date11 - 13 June,
Monday, June 11th, 12:00 pm Luncheon Presentation: Ultra-Sensitive Detection of Proteomic and Genomic Immuno-Oncology Biomarkers Using SIMOA (Single Molecule Array)
Dan Sikkema, Vice President, Accelerator Services, Quanterix
Presentation Abstract: Advances in immuno-oncology in recent years have benefited from the appropriate selection of biomarkers for diagnosis and predicting treatment benefit, as well as monitoring efficacy and safety post-treatment. Use of readily available specimen types such as serum or saliva will permit more frequent and cost-effective monitoring of health status. The ability to measure low-frequency proteins combined with direct detection of genomic (ctDNA, microRNA) material with a single technology will provide new advancements to the field.
Cambridge Healthtech Institute’s Fourteenth Annual Biomarkers and Immuno-Oncology World Congress, now in Boston, is CHI’s longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. Learn more.
Share this page